Posts Tagged ‘insulin inhaler’

Mealtime Insulin Injections May be Replaced by an Insulin Inhaler

August 12, 2011 by · Leave a Comment
Filed under: Diabetes Control, Diabetes Medication, Diabetes Research and News, Insulin Delivery 
Social Tagging: • • • • • • • •

There’s good news for insulin dependent diabetics who rely on fast-acting mealtime insulin injections to keep their blood sugar under control. MannKind Corporation has the go-ahead to continue clinical testing of its investigational inhaled insulin, AFREZZA. The drug maker and the FDA met to confirm the protocols for two new studies, one in type 1 diabetics, and one in type 2 diabetics.

AFREZZA is an ultra-rapid acting inhaled insulin which uses patented technology to deliver powdered insulin from a thumb-sized device into the lungs. The lungs are an effective option for delivering diabetes medication, largely because of their huge surface area (about the size of a tennis court). Read the full article

Insulin Therapy Changing With New and Improved Insulin Delivery Methods

April 14, 2011 by · Leave a Comment
Filed under: Diabetes Research and News, Insulin Delivery, Insulin Injections 
Social Tagging: • • • • • • • •

An old insulin syringe

Old insulin syringe. Photo: Markus.Michalczyk

Not that long ago, being insulin dependent meant you had to carry around a syringe and a vial of insulin to deliver your insulin injections, making sure to keep them refrigerated. There are now a variety of methods for insulin delivery on the market, and some promising new developments on the horizon. These include:

1) Insulin pens. Most types of insulin are now available in convenient prefilled pens. Some insulin pens are entirely disposable when empty, and others use a replaceable insulin cartridge, usually containing 300 units. There is a dial on one end to set your desired dose. The pens offer discreet, push button insulin delivery. Some claim the injections are more comfortable than from a needle that has already been dulled by insertion into an insulin vial. Many people prefer to use an insulin pen if they are caring for a diabetic child or pet.
Read the full article

Injection-Free Insulin Inhaler Awaiting FDA Approval

January 24, 2011 by · 1 Comment
Filed under: Diabetes Research and News, Insulin Delivery 
Social Tagging: • • • • • •

Photo credit: djeyewater

A new injection-free insulin inhaler is awaiting FDA approval for the treatment of both type 1 and type 2 diabetes.  Insulin can’t be taken orally, as digestive juices break it down before it can be used by the body. Currently, the only means of delivering insulin are subcutaneous insulin injections or intravenously.

AFREZZA is an ultra-rapid acting inhaled insulin developed by MannKind Corporation. It uses patented Technospere technology to deliver powdered insulin from a thumb-sized device into the lungs. The lungs are an effective option for delivering diabetes medication, largely because of their huge surface area (about the size of a single tennis court).
Read the full article